Altered GABAergic and glutamatergic activity within the rat hippocampus and amygdala in rats subjected to repeated corticosterone administration but not restraint stress

Neuroscience

Volumn 231, Issue , 2013, Pages 38-48

  Lussier, A L ^a   Romay Tallon R ^b   Caruncho, H J ^b   Kalynchuk, L E ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Amygdala; Corticosterone; GABA; Glutamate; Hippocampus; Stress

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA2; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA3; 4 AMINOBUTYRIC ACID A RECEPTOR BETA2; 4 AMINOBUTYRIC ACID A RECEPTOR BETA3; CORTICOSTERONE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; VESICULAR GLUTAMATE TRANSPORTER 2;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEPRESSION; GABAERGIC SYSTEM; GLUTAMATERGIC SYSTEM; HIPPOCAMPUS; IMMOBILIZATION STRESS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

AMYGDALA; ANIMALS; BEHAVIOR, ANIMAL; CORTICOSTERONE; DEPRESSION; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; GLUTAMATE DECARBOXYLASE; HIPPOCAMPUS; MALE; RATS; RATS, LONG-EVANS; RECEPTORS, GABA-A; RESTRAINT, PHYSICAL; STRESS, PHYSIOLOGICAL; VESICULAR GLUTAMATE TRANSPORT PROTEIN 2;

EID: 84871731238     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.11.037     Document Type: Article

References (82)

1. Altamura C.A., Mauri M.C., Ferrara A., Moro A.R., D'Andrea G., Zamberlan F. Plasma and platelet excitatory amino acids in psychiatric disorders. Am J Psychiatry 1993, 150:1731-1733.
2. Angelotti T.P., Uhler M.D., Macdonald R.L. Assembly of GABAA receptor subunits: analysis of transient single-cell expression utilizing a fluorescent substrate/marker gene technique. J Neurosci 1993, 13:1418-1428.
3. Brambilla P., Perez J., Barale F., Schettini G., Soares J.C. GABAergic dysfunction in mood disorders. Mol Psychiatry 2003, 8:721-737.
4. Brummelte S., Galea L.A. Chronic high corticosterone reduces neurogenesis in the dentate gyrus of adult male and female rats. Neuroscience 2010, 168:680-690.
5. Brummelte S., Pawluski J.L., Galea L.A. High post-partum levels of corticosterone given to dams influence postnatal hippocampal cell proliferation and behavior of offspring: a model of post-partum stress and possible depression. Horm Behav 2006, 50:370-382.
6. Burt D.R., Kamatchi G.L. GABAA receptor subtypes: from pharmacology to molecular biology. FASEB J 1991, 5:2916-2923.
7. Coburn-Litvak P.S., Pothakos K., Tata D.A., McCloskey D.P., Anderson B.J. Chronic administration of corticosterone impairs spatial reference memory before spatial working memory in rats. Neurobiol Learn Mem 2003, 80:11-23.
8. Connolly K.R., Thase M.E. Emerging drugs for major depressive disorder. Expert Opin Emerg Drugs 2012, 17:105-126.
9. Cullinan W.E., Herman J.P., Watson S.J. Ventral subicular interaction with the hypothalamic paraventricular nucleus: evidence for a relay in the bed nucleus of the stria terminalis. J Comp Neurol 1993, 332:1-20.
10. Drugan R.C., Morrow A.L., Weizman R., Weizman A., Deutsch S.I., Crawley J.N., Paul S.M. Stress-induced behavioral depression in the rat is associated with a decrease in GABA receptor-mediated chloride ion flux and brain benzodiazepine receptor occupancy. Brain Res 1989, 487:45-51.
11. Elizalde N., Garcia-Garcia A.L., Totterdell S., Gendive N., Venzala E., Ramirez M.J., Del Rio J., Tordera R.M. Sustained stress-induced changes in mice as a model for chronic depression. Psychopharmacol 2010, 210:393-406.
12. Erlander M.G., Tillakaratne N.J., Feldblum S., Patel N., Tobin A.J. Two genes encode distinct glutamate decarboxylases. Neuron 1991, 7:91-100.
13. Esclapez M., Tillakaratne N.J., Kaufman D.L., Tobin A.J., Houser C.R. Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms. J Neurosci 1994, 14:1834-1855.
14. Fatemi S.H., Stary J.M., Earle J.A., Raghi-Niknam M., Eagan E. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67kDa and Reelin proteins in cerebellum. Schizophr Res 2005, 72:109-122.
15. Fava M., McCall W.V., Krystal A., Wessel T., Rubens R., Caron J., Amato D., Roth T. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry 2006, 59:1052-1060.
16. Fava M., Schaefer K., Huang H., Wilson A., Iosifescu D.V., Mischoulon D., Wessel T.C. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression. J Clin Psychiatry 2011, 72:473-479.
17. Fritschy J.M., Mohler H. GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J Comp Neurol 1995, 359:154-194.
18. Frotscher M., Haas C.A., Forster E. Reelin controls granule cell migration in the dentate gyrus by acting on the radial glial scaffold. Cereb Cortex 2003, 13:634-640.
19. Galea L.A., McEwen B.S., Tanapat P., Deak T., Spencer R.L., Dhabhar F.S. Sex differences in dendritic atrophy of CA3 pyramidal neurons in response to chronic restraint stress. Neuroscience 1997, 81:689-697.
20. Garcia-Garcia A.L., Elizalde N., Matrov D., Harro J., Wojcik S.M., Venzala E., Ramirez M.J., Del Rio J., Tordera R.M. Increased vulnerability to depressive-like behavior of mice with decreased expression of VGLUT1. Biol Psychiatry 2009, 66:275-282.
21. Ge S., Goh E.L., Sailor K.A., Kitabatake Y., Ming G.L., Song H. GABA regulates synaptic integration of newly generated neurons in the adult brain. Nature 2006, 439:589-593.
22. Gerner R.H., Hare T.A. CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa. Am J Psychiatry 1981, 138:1098-1101.
23. Goeders N.E., De Souza E.B., Kuhar M.J. Benzodiazepine receptor GABA ratios: regional differences in rat brain and modulation by adrenalectomy. Eur J Pharmacol 1986, 129:363-366.
24. Gong C., Wang T.W., Huang H.S., Parent J.M. Reelin regulates neuronal progenitor migration in intact and epileptic hippocampus. J Neurosci 2007, 27:1803-1811.
25. Gorzalka B., Hanson L., Harrington J., Killam S., Campbell-Meiklejohn D. Conditioned taste aversion: modulation by 5-HT receptor activity and corticosterone. Eur J Pharmacol 2003, 471:129-134.
26. Gorzalka B.B., Hanson L.A., Brotto L.A. Chronic stress effects on sexual behavior in male and female rats: mediation by 5-HT2A receptors. Pharmacol Biochem Behav 1998, 61:405-412.
27. Gourley S.L., Kiraly D.D., Howell J.L., Olausson P., Taylor J.R. Acute hippocampal brain-derived neurotrophic factor restores motivational and forced swim performance after corticosterone. Biol Psychiatry 2008, 64:884-890.
28. Gray M., Innala L., Viau V. Central vasopressin V1A receptor blockade impedes hypothalamic-pituitary-adrenal habituation to repeated restraint stress exposure in adult male rats. Neuropsychopharmacology 2012, 37:2712-2719.
29. Gregus A., Wintink A.J., Davis A.C., Kalynchuk L.E. Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats. Behav Brain Res 2005, 156:105-114.
30. Grissom N., Iyer V., Vining C., Bhatnagar S. The physical context of previous stress exposure modifies hypothalamic-pituitary-adrenal responses to a subsequent homotypic stress. Horm Behav 2007, 51:95-103.
31. Gronli J., Fiske E., Murison R., Bjorvatn B., Sorensen E., Irsin R., Portas C.M. Extracellular levels of serotonin and GABA in the hippocampus after chronic mild stress in rats. A microdialysis study in an animal model of depression. Behav Brain Res 2007, 181:42-51.
32. Herz J., Chen Y. Reelin, lipoprotein receptors and synaptic plasticity. Nat Rev Neurosci 2006, 7:850-859.
33. Hill M.N., Brotto L.A., Lee T.T., Gorzalka B.B. Corticosterone attenuates the antidepressant-like effects elicited by melatonin in the forced swim test in both male and female rats. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:905-911.
34. Itoh M., Uchimura H. Regional differences in cofactor saturation of glutamate decarboxylase (GAD) in discrete brain nuclei of the rat. Effect of repeated administration of haloperidol on GAD activity in the substantia nigra. Neurochem Res 1981, 6:1283-1289.
35. Jagasia R., Steib K., Englberger E., Herold S., Faus-Kessler T., Saxe M., Gage F.H., Song H., Lie D.C. GABA-cAMP response element-binding protein signaling regulates maturation and survival of newly generated neurons in the adult hippocampus. J Neurosci 2009, 29:7966-7977.
36. Johnson S.A., Fournier N.M., Kalynchuk L.E. Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor. Behav Brain Res 2006, 168:280-288.
37. Kalynchuk L.E., Gregus A., Boudreau D., Perrot-Sinal T.S. Corticosterone increases depression-like behavior, with some effects on predator odor-induced defensive behavior, in male and female rats. Behav Neurosci 2004, 118:1365-1377.
38. Karolewicz B., Maciag D., O'Dwyer G., Stockmeier C.A., Feyissa A.M., Rajkowska G. Reduced level of glutamic acid decarboxylase-67kDa in the prefrontal cortex in major depression. Int J Neuropsychopharmacol 2010, 13:411-420.
39. Kasa K., Otsuki S., Yamamoto M., Sato M., Kuroda H., Ogawa N. Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders. Biol Psychiatry 1982, 17:877-883.
40. Kaufman D.L., Houser C.R., Tobin A.J. Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J Neurochem 1991, 56:720-723.
41. Kaufmann W.A., Humpel C., Alheid G.F., Marksteiner J. Compartmentation of alpha 1 and alpha 2 GABA(A) receptor subunits within rat extended amygdala: implications for benzodiazepine action. Brain Res 2003, 964:91-99.
42. 11C]flumazenil binding in major depression: preliminary results. Eur J Nucl Med Mol Imaging 2010, 37:565-574.
43. Krystal A., Fava M., Rubens R., Wessel T., Caron J., Wilson P., Roth T., McCall W.V. Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression. J Clin Sleep Med 2007, 3:48-55.
44. Krystal J.H., Sanacora G., Blumberg H., Anand A., Charney D.S., Marek G., Epperson C.N., Goggard A., Mason G.F. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry 2002, 7(Suppl. 1):S71-S80.
45. Levine J., Panchalingam K., Rapoport A., Gershon S., McClure R.J., Pettegrew J.W. Increased cerebrospinal fluid glutamine levels in depressed patients. Biol Psychiatry 2000, 47:586-593.
46. Lussier A.L., Caruncho H.J., Kalynchuk L.E. Repeated exposure to corticosterone, but not restraint, decreases the number of reelin-positive cells in the adult rat hippocampus. Neurosci Lett 2009, 460:170-174.
47. Lussier A.L., Romay-Tallon R., Kalynchuk L.E., Caruncho H.J. Reelin as a putative vulnerability factor for depression: examining the depressogenic effects of repeated corticosterone in heterozygous reeler mice. Neuropharmacology 2011, 60:1064-1074.
48. Marks W., Fournier N.M., Kalynchuk L.E. Repeated exposure to corticosterone increases depression-like behavior in two different versions of the forced swim test without altering nonspecific locomotor activity or muscle strength. Physiol Behav 2009, 98:67-72.
49. Martin D.L., Martin S.B., Wu S.J., Espina N. Regulatory properties of brain glutamate decarboxylase (GAD): the apoenzyme of GAD is present principally as the smaller of two molecular forms of GAD in brain. J Neurosci 1991, 11:2725-2731.
50. Martin D.L., Rimvall K. Regulation of gamma-aminobutyric acid synthesis in the brain. J Neurochem 1993, 60:395-407.
51. Martisova E., Solas M., Horrillo I., Ortega J.E., Meana J.J., Tordera R.M., Ramirez M.J. Long lasting effects of early-life stress on glutamatergic/GABAergic circuitry in the rat hippocampus. Neuropharmacology 2012, 62:1944-1953.
52. Mathew S.J., Shah A., Lapidus K., Clark C., Jarun N., Ostermeyer B., Murrough J.W. Ketamine for treatment-resistant unipolar depression: current evidence. CNS Drugs 2012, 26:189-204.
53. Miller L.G., Greenblatt D.J., Barnhill J.G., Thompson M.L., Shaderh R.I. Modulation of benzodiazepine receptor binding in mouse brain by adrenalectomy and steroid replacement. Brain Res 1988, 446:314-320.
54. Mitani H., Shirayama Y., Yamada T., Maeda K., Ashby C.R., Kawahara R. Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:1155-1158.
55. Moechars D., Weston M.C., Leo S., Callaerts-Vegh Z., Goris I., Daneels G., Buist A., Cik M., van der Spek P., Kass S., Meert T., D'Hooge R., Rosenmund C., Hampson R.M. Vesicular glutamate transporter VGLUT2 expression levels control quantal size and neuropathic pain. J Neurosci 2006, 26:12055-12066.
56. Niu S., Yabut O., D'Arcangelo G. The reelin signaling pathway promotes dendritic spine development in hippocampal neurons. J Neurosci 2008, 28:10339-10348.
57. Orchinik M., Weiland N.G., McEwen B.S. Chronic exposure to stress levels of corticosterone alters GABAA receptor subunit mRNA levels in rat hippocampus. Brain Res Mol Brain Res 1995, 34:29-37.
58. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, New York.
59. Pesold C., Impagnatiello F., Pisu M.G., Uzunov D.P., Costa E., Guidotti A., Caruncho H.J. Reelin is preferentially expressed in neurons synthesizing gamma-aminobutyric acid in cortex and hippocampus of adult rats. Proc Natl Acad Sci U S A 1998, 95:3221-3226.
60. Petty F., Kramer G.L., Gullion C.M., Rush A.J. Low plasma gamma-aminobutyric acid levels in male patients with depression. Biol Psychiatry 1992, 32:354-363.
61. Pirker S., Schwarzer C., Wieselthaler A., Sieghart W., Sperk G. GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 2000, 101:815-850.
62. Pujadas L., Gruart A., Bosch C., Delgado L., Teixeira C.M., Rossi D., de Lecea L., Martinez A., Delgado-Garcia J.M., Soriano E. Reelin regulates postnatal neurogenesis and enhances spine hypertrophy and long-term potentiation. J Neurosci 2010, 30:4636-4649.
63. Qiu S., Zhao L.F., Korwek K.M., Weeber E.J. Differential reelin-induced enhancement of NMDA and AMPA receptor activity in the adult hippocampus. J Neurosci 2006, 26:12943-12955.
64. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Meltzer H.Y., Overholser J.C., Roth B.L., Stickmaier C.A. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999, 45:1085-1098.
65. Rajkowska G., O'Dwyer G., Teleki Z., Stockmeier C.A., Miguel-Hidalgo J.J. GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology 2007, 32:471-482.
66. Sanacora G., Mason G.F., Krystal J.H. Impairment of GABAergic transmission in depression: new insights from neuroimaging studies. Crit Rev Neurobiol 2000, 14:23-45.
67. Sanacora G., Mason G.F., Rothman D.L., Behar K.L., Hyder F., Petroff O.A., Berman R.M., Charney D.S., Krystal J.H. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 1999, 56:1043-1047.
68. Sanacora G., Mason G.F., Rothman D.L., Hyder F., Ciarcia J.J., Ostroff R.B., Berman R.M., Krystal J.H. Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry 2003, 160:577-579.
69. Sanacora G., Mason G.F., Rothman D.L., Krystal J.H. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 2002, 159:663-665.
70. Sanger D.J., Benavides J., Perrault G., Morel E., Cohen C., Joly D., Zivkovic B. Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes. Neurosci Biobehav Rev 1994, 18:355-372.
71. Sernagor E., Chabrol F., Bony G., Cancedda L. GABAergic control of neurite outgrowth and remodeling during development and adult neurogenesis: general rules and differences in diverse systems. Front Cell Neurosci 2010, 4:11.
72. Smith K.S., Rudolph U. Anxiety and depression: mouse genetics and pharmacological approaches to the role of GABA(A) receptor subtypes. Neuropharmacology 2012, 62:54-62.
73. Sousa N., Lukoyanov N.V., Madeira M.D., Almeida O.F., Paula-Barbosa M.M. Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement. Neuroscience 2000, 97:253-266.
74. Sterner E.Y., Kalynchuk L.E. Behavioral and neurobiological consequences of prolonged glucocorticoid exposure in rats: relevance to depression. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:777-790.
75. Takamori S. VGLUTs: 'exciting' times for glutamatergic research?. Neurosci Res 2006, 55:343-351.
76. Tozuka Y., Fukuda S., Namba T., Seki T., Hisatsune T. GABAergic excitation promotes neuronal differentiation in adult hippocampal progenitor cells. Neuron 2005, 47:803-815.
77. Verkuyl J.M., Karst H., Joels M. GABAergic transmission in the rat paraventricular nucleus of the hypothalamus is suppressed by corticosterone and stress. Eur J Neurosci 2005, 21:113-121.
78. Vollenweider I., Smith K.S., Keist R., Rudolph U. Antidepressant-like properties of alpha2-containing GABA(A) receptors. Behav Brain Res 2011, 217:77-80.
79. 3H]Ro15-1788 binding to GABAA benzodiazepine receptors in the mouse. Brain Res 1990, 519:347-350.
80. Wilson M.A., Biscardi R. Sex differences in GABA/benzodiazepine receptor changes and corticosterone release after acute stress in rats. Exp Brain Res 1994, 101:297-306.
81. Wong E.Y., Herbert J. Raised circulating corticosterone inhibits neuronal differentiation of progenitor cells in the adult hippocampus. Neuroscience 2006, 137:83-92.
82. Zhao Y., Ma R., Shen J., Su H., Xing D., Du L. A mouse model of depression induced by repeated corticosterone injections. Eur J Pharmacol 2008, 581:113-120.